Picture of Neodynamics AB (publ) logo

NEOD Neodynamics AB (publ) Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-2.84%
3m-42.6%
6m-77.77%
1yr-97.62%
Volume Change (%)
10d/3m-67.69%
Price vs... (%)
52w High-97.9%
50d MA-6.27%
200d MA-79.98%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-218.63%
Return on Equity-147.47%
Operating Margin-28334.89%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Neodynamics AB (publ) EPS forecast chart

Profile Summary

NeoDynamics AB (publ) is a Sweden-based company engaged in the medical industry. The Company focuses on developing and commercializing products for breast cancer screening, imaging, and breast cancer treatments. The Company’s product NeoNavia, enables a pulse biopsy system for ultrasound guided tissue sampling. It consists of a base unit, a handheld driver and three different types of biopsy needles. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumour whilst enabling tissue samples from both breasts and lymph nodes. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at clinics in United Kingdom, Germany, and Sweden.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    May 26th, 2015
    Public Since
    December 7th, 2018
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    se flag iconOMX Nordic Exchange Stockholm
    Shares in Issue
    32,606,779

    NEOD Share Price Performance

    Upcoming Events for NEOD

    Neodynamics AB (publ) Annual Shareholders Meeting

    Similar to NEOD

    Picture of Acarix AB logo

    Acarix AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of ADDvise AB (publ) logo

    ADDvise AB (publ)

    se flag iconOMX Nordic Exchange Stockholm

    Picture of ADDvise AB (publ) logo

    ADDvise AB (publ)

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Aegirbio AB logo

    Aegirbio AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Arcoma AB logo

    Arcoma AB

    se flag iconOMX Nordic Exchange Stockholm

    FAQ